Skip to main content
. 2022 Feb 26;39(4):973–976. doi: 10.1007/s10815-022-02444-w

Fig. 2.

Fig. 2

A Weight trends are demonstrated in the 12 months prior to the first cycle, in the month when the first cycle ovarian stimulation medications were received, and in the first trimester of pregnancy of the first cycle. B Weight trends are demonstrated in the 12 months prior to the second cycle, in the month when the second cycle ovarian stimulation medications were received, during the 4-month interlude between the second and third cycles, in the month when the third cycle ovarian stimulation medications were received, and in the first trimester of pregnancy of the third cycle. Anti-obesity medications were terminated prior to initiating all the three cycles. Red dotted lines demark the period when ovarian stimulation medications are received